Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (OTC Pink - Current Information:NONOF)

46.25
Delayed Data
As of Aug 26
 -1.40 / -2.94%
Today’s Change
46.00
Today|||52-Week Range
59.40
-19.35%
Year-to-Date
Pharmaceuticals are the New Bonds
Aug 26 / GuruFocus News - Paid Partner Content
Novo Nordisk A/S Focuses on New Drugs
Aug 16 / MotleyFool.com - Paid Partner Content
Better Buy: AbbVie Inc. vs. Eli Lilly & Co.
Aug 17 / MotleyFool.com - Paid Partner Content
3 Beaten-Up Big Pharma Stocks: Are They Bargains?
Aug 14 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close47.65
Today’s open47.20
Day’s range46.25 - 47.20
Volume12,205
Average volume (3 months)41,851
Market cap$95.9B
Dividend yield1.95%
Data as of 12:52pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+12.17%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+1.54%
P/E ratio--
Price/Sales9.35
Price/Book17.76

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$16.0B
Annual profit (last year)$5.2B
Net profit margin32.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Rebien Sørensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts

Partner Offers

Search for Jobs